Neurological illnesses associated with Florida red tide (Karenia brevis) blooms.

Karenia brevis (K. brevis) brevetoxin exposure-response headache illness cost

Journal

Harmful algae
ISSN: 1878-1470
Titre abrégé: Harmful Algae
Pays: Netherlands
ID NLM: 101128968

Informations de publication

Date de publication:
02 2019
Historique:
received: 06 03 2018
revised: 07 07 2018
accepted: 07 07 2018
entrez: 1 4 2019
pubmed: 1 4 2019
medline: 23 2 2020
Statut: ppublish

Résumé

Human respiratory and gastrointestinal illnesses can result from exposures to brevetoxins originating from coastal Florida red tide blooms, comprising the marine alga Karenia brevis (K. brevis). Only limited research on the extent of human health risks and illness costs due to K. brevis blooms has been undertaken to date. Because brevetoxins are known neurotoxins that are able to cross the blood-brain barrier, it is possible that exposure to brevetoxins may be associated with neurological illnesses. This study explored whether K. brevis blooms may be associated with increases in the numbers of emergency department visits for neurological illness. An exposure-response framework was applied to test the effects of K. brevis blooms on human health, using secondary data from diverse sources. After controlling for resident population, seasonal and annual effects, significant increases in emergency department visits were found specifically for headache (ICD-9 784.0) as a primary diagnosis during proximate coastal K. brevis blooms. In particular, an increased risk for older residents (≥55 years) was identified in the coastal communities of six southwest Florida counties during K. brevis bloom events. The incidence of headache associated with K. brevis blooms showed a small but increasing association with K. brevis cell densities. Rough estimates of the costs of this illness were developed for hypothetical bloom occurrences.

Identifiants

pubmed: 30928012
pii: S1568-9883(18)30103-3
doi: 10.1016/j.hal.2018.07.002
pmc: PMC9933543
mid: NIHMS1860788
pii:
doi:

Substances chimiques

Neurotoxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-81

Subventions

Organisme : NIEHS NIH HHS
ID : P01 ES010594
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES005705
Pays : United States
Organisme : NIEHS NIH HHS
ID : P50 ES012736
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Références

Environ Health Perspect. 2005 May;113(5):618-20
pubmed: 15866773
Harmful Algae. 2010 Jan 1;9(1):82-86
pubmed: 20161425
J Epidemiol Community Health. 2000 Jul;54(7):502-9
pubmed: 10846192
Environ Health Perspect. 2009 Aug;117(8):1239-43
pubmed: 19672403
JAMA. 2003 Nov 12;290(18):2443-54
pubmed: 14612481
Harmful Algae. 2010 Feb 1;9(2):186-189
pubmed: 20161504
N Engl J Med. 1996 Mar 7;334(10):642-6
pubmed: 8592529
Harmful Algae. 2011 Jan 1;10(2):224-233
pubmed: 21218152
Toxicon. 2006 Dec 15;48(8):1018-26
pubmed: 17011606
Harmful Algae. 2010 Sep 1;9(6):600-606
pubmed: 20824108
Harmful Algae. 2011 Jan 1;10(2):138-143
pubmed: 21499552
Environ Health Perspect. 2009 Jul;117(7):1095-100
pubmed: 19654919
Harmful Algae. 2011 Sep 1;10(6):744-748
pubmed: 22053149
Environ Health Perspect. 2005 May;113(5):644-9
pubmed: 15866778
Harmful Algae. 2006 Oct 1;5(5):526-533
pubmed: 20357898
J Headache Pain. 2008 Jun;9(3):139-46
pubmed: 18418547
Harmful Algae. 2011 May 1;10(4):374-380
pubmed: 21532966
Mar Drugs. 2008;6(3):456-79
pubmed: 19005579
J Gen Intern Med. 2004 Oct;19(10):1005-12
pubmed: 15482552
Toxicon. 1965 Nov;3(2):111-23
pubmed: 5867066
J Asthma. 2007 Sep;44(7):583-7
pubmed: 17885863
Chest. 2007 Jan;131(1):187-94
pubmed: 17218574
Eur J Neurol. 2012 Jan;19(1):155-62
pubmed: 22175760
Mar Drugs. 2008;6(3):431-55
pubmed: 19005578
Environ Health Perspect. 2005 May;113(5):650-7
pubmed: 15866779
Curr Treat Options Neurol. 2013 Feb;15(1):56-62
pubmed: 23054583
Environ Health Perspect. 2005 May;113(5):638-43
pubmed: 15866777
J Int Neuropsychol Soc. 2005 May;11(3):331-8
pubmed: 15892909
Arch Clin Neuropsychol. 2007 May;22(4):545-53
pubmed: 17482422
Mar Drugs. 2017 Mar 14;15(3):
pubmed: 28335428
Environ Int. 2014 Jul;68:144-53
pubmed: 24727069

Auteurs

Roberto Efrain Diaz (RE)

Department of Health Management and Policy, University of Miami, Coral Gables, FL, USA.

Melissa A Friedman (MA)

Mount Sinai Medical Center, Miami Beach, FL, USA.

Di Jin (D)

Marine Policy Center, Woods Hole Oceanographic Institution, Woods Hole, MA, USA.

Andrew Beet (A)

Marine Policy Center, Woods Hole Oceanographic Institution, Woods Hole, MA, USA.

Barbara Kirkpatrick (B)

Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami, Miami, FL, USA; Mote Marine Laboratory, Sarasota, FL, USA.

Andrew Reich (A)

Aquatic Toxins Program, Bureau of Epidemiology, Florida Department of Health, Tallahassee, FL, USA.

Gary Kirkpatrick (G)

Mote Marine Laboratory, Sarasota, FL, USA.

Steven G Ullmann (SG)

Department of Health Management and Policy, University of Miami, Coral Gables, FL, USA. Electronic address: sullmann@bus.miami.edu.

Lora E Fleming (LE)

Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami, Miami, FL, USA; European Centre for Environment and Human Health, University of Exeter Medical School, Truro, Cornwall, UK.

Porter Hoagland (P)

Marine Policy Center, Woods Hole Oceanographic Institution, Woods Hole, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH